Cerity Partners’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.05M Sell
14,416
-51
-0.4% -$9.36K ﹤0.01% 1339
2026
Q1
$2.31M Sell
14,467
-4,450
-24% -$683K ﹤0.01% 1409
2025
Q4
$2.59M Sell
18,917
-7,897
-29% -$1.02M ﹤0.01% 1259
2025
Q3
$3.26M Buy
26,814
+1,414
+6% +$153K 0.01% 1066
2025
Q2
$2.72M Buy
25,400
+2,521
+11% +$252K ﹤0.01% 1076
2025
Q1
$2.12M Buy
22,879
+5,115
+29% +$496K ﹤0.01% 1101
2024
Q4
$1.92M Buy
17,764
+1,133
+7% +$138K ﹤0.01% 1122
2024
Q3
$2.09M Buy
16,631
+825
+5% +$104K ﹤0.01% 1075
2024
Q2
$1.71M Sell
15,806
-544
-3% -$53K ﹤0.01% 972
2024
Q1
$1.55M Buy
+16,350
New +$1.55M ﹤0.01% 1087

Other funds holding NHC

Cerity Partners's NHC Position: Q2 2026 in Review

Cerity Partners reduced its National Healthcare (NHC) stake by 0.35% in Q2 2026, selling an estimated $9.36K and leaving 14,416 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Cerity Partners first reported a position in NHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.26M in Q3 2025. 235 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

  • Cerity Partners held 14,416 shares of National Healthcare worth $3.05M as of Q2 2026.
  • Cerity Partners sold 51 National Healthcare shares in Q2 2026, an estimated $9.36K.
  • National Healthcare made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1339 holding.
  • Cerity Partners first reported a position in National Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Cerity Partners's National Healthcare position peaked at $3.26M in Q3 2025.
  • 235 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.